In the actively immunized experimental autoimmune myasthenia gravis mice deficient in either CD55 or CD59, a significant increase in complement deposition at the end-plates was observed and worsened disease outcome associated with increased levels of serum cytokines was observed [50]. Here, CD59 is linked to myasthenia gravis.